Single-Use Bioreactor Stabilized Polyolefin with Alpha-Tocopherol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional single-use bioprocess equipment made from plastics can leach toxic substances like bis(2,4-di-tert-butylphenyl)phosphate, affecting cell growth and requiring costly testing and validation, while traditional metal or glass systems have their own limitations in biopharmaceutical production.
Innovation Solution
A stabilized polyolefin composition comprising a copolymer of ethylene and α-olefin with α-tocopherol, which provides a bio-inspired antioxidant package, reducing oxidative degradation and minimizing the leaching of toxic substances, thereby enhancing processing stability and safety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If conventional plastics with traditional stabilizers are used for single-use bioprocess equipment, then mechanical properties and processing stability are improved, but toxic substances leach into the bioprocess affecting cell growth
Solution Approach 1:
The patent changes the chemical composition parameters of the stabilizer package by replacing traditional synthetic phenolic antioxidants with a bio-inspired antioxidant system based on vitamin E (tocopherols) and vitamin C (ascorbic acid) derivatives. This substitution maintains the stabilizing function while eliminating toxicity, directly resolving the contradiction between mechanical strength and harmful leaching
Solution Approach 2:
The patent applies the disposable nature of single-use bioprocess equipment to justify using a specialized stabilizer package optimized for short-term performance. The stabilizers are selected to provide adequate mechanical properties during the brief operational lifetime of the equipment while ensuring no toxic leaching occurs during this limited service period
2Stability of the object's composition
If traditional synthetic antioxidants are used to stabilize polyolefin compositions, then processing stability is improved, but contamination of food and pharmaceutical products with toxic substances occurs
Solution Approach 1:
The patent converts the potential harm of antioxidant leaching into a benefit by selecting antioxidants that are themselves beneficial substances (vitamins). The vitamin E and vitamin C derivatives provide both the necessary processing stability and act as safe, beneficial components in food and pharmaceutical contact applications, eliminating contamination concerns
Solution Approach 2:
The patent changes the chemical identity parameters of the antioxidants from synthetic phenolic compounds to natural vitamin-based compounds. This parameter change maintains the radical scavenging mechanism needed for processing stability while fundamentally altering the safety profile to eliminate toxicity and contamination risks
3Productivity
If single-use systems are implemented to avoid cleaning and sterilization, then productivity and cost are improved, but validation of material safety becomes more critical and costly
Solution Approach 1:
The patent performs preliminary action by pre-selecting and incorporating food-grade, pharmaceutical-grade stabilizers into the polyolefin composition during manufacturing. This preliminary safety assurance eliminates the need for extensive post-manufacturing validation testing, reducing both time and cost while maintaining high productivity
Solution Approach 2:
The stabilizer package is designed to be inherently safe and self-validating. The use of well-known safe substances (vitamins) with established safety profiles allows the material to self-prove its safety without requiring complex external validation processes, thus supporting high productivity without compromising reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition improves processing stability, reduces the risk of toxic substance migration, and ensures safer biopharmaceutical production by eliminating the need for costly testing and validation, while maintaining mechanical properties suitable for film applications.
Implementation Method 1
a stabilized polyolefin composition comprising a copolymer of ethylene and at least one α-olefin with α-tocopherol, which provides a bio-inspired antioxidant package, reducing oxidative degradation
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The disclsoure relates to a bioreactor comprising at least one sheet of polymer material formed from a composition comprising: A. a copolymer of ethylene and at least one α-olefin; and B. between 25 and 300 ppm by weight of α-tocopherol relative to the component A.